Strategies and tactics to help hospitals and health systems prepare their operations and clinical teams for a fast-evolving emergency situation.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Evaluating healthcare workforce supply and demand.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

The must-do surge planning for hospital and health system providers to lead their organizations successfully through COVID-19.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Employers should make their people a top priority and work to protect their health and keep them well-informed.

Vice President, Marsh
Partner, Health and Benefits, Mercer

When COVID-19 is Found in Your Area, What’s Your Game Plan?

Important considerations for all healthcare providers navigating the effects of coronavirus.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Five things for payers to keep in mind as they look to tap into the booming primary care market.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

We must plan and prepare for resilience as businesses and as a society.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Healthcare systems know M&A, cost transformation, and SDOH can reap big rewards. Bold models will thrive.

A one-size-fits-all SDOH approach isn't the answer. Yet it's the industry norm.

Executive Founder, Wellville
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More